Now showing items 1064-1083 of 1119

    • Singhal, Pooja; Wilson, Thomas S.; Cosgriff-hernandez, Elizabeth; Maitland, Duncan J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-12-12)
      Compositions and/or structures of degradable shape memory polymers (SMPs) ranging in form from neat/unfoamed to ultra low density materials of down to 0.005 g/cc density. These materials show controllable degradation rate, ...
    • Kinra, Vikram K. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1994-04-19)
      In the field of non-destructive evaluation of materials, conventional ultrasonic measurement techniques are limited to materials having a thickness which is relatively large compared to the wavelength of the ultrasonic ...
    • Valasek, John; May, James Franklin; Beckett, Andrew; Rhodes, Cecil C., Jr. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-05-01)
      The present invention relates to an aircraft. The aircraft includes a fuselage module for receiving a payload. The fuselage module includes a plurality of internal connections. The aircraft includes a wing module adjustably ...
    • Toliyat, Hamid A.; Gopalarathnam, Tilak (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2006-05-23)
      A unipolar drive includes a booster, an energy storage module, and a unipolar inverter. The booster increase a voltage received from a power supply to produce an energy output. The energy storage module store at least some ...
    • Summers, Max D.; Braunagel, Sharon C.; Hong, Tao (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2000-01-25)
      Provided are hydrophobic targeting sequences, which may serve to target heterologous proteins to a variety of cellular membranes. In particular, the structural components of the nuclear envelope, or those components which ...
    • Gaines, Michael G.; King, George R.; Schmitt, Kenneth J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2006-02-21)
      The present invention comprises a unitized MEA assembly for use in a fuel cell or a fuel cell stack assembly. In the embodiments of the invention, the MEA is made integral to the frame to reduce certain risks and disadvantages ...
    • Cirillo, Jeffrey D.; Rao, Jianghong (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2016-09-13)
      Provided herein are assays and in vitro methods to determine susceptibility to a drug effective against a pathogenic bacteria, for example, a pathogenic Mycobacteria, that has a beta-lactamase activity. An excitation ...
    • Cirillo, Jeffrey D.; Sacchettini, James C.; Rao, Jianghong; Xie, Hexin (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-09-22)
      Provided herein are methods for detecting, quantifying, differentiating, diagnosing and imaging pathogenic bacteria or condition associated therewith using substrates for bacterial enzymes. Fluorescent, luminescent or ...
    • Legocki, Roman P.; Legocki, Misuk; Szalay, Aladar A.; Baldwin, Thomas O. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1993-06-22)
      A host microorganism is genetically and stably modified by the insertion into any of its non-essential chromosomal location of a non-homologous, recombinant foreign DNA fragment, maintaining an insertion of a luxAB gene ...
    • Guarino, Linda A.; Jarvis, Donald L. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1991-12-31)
      The present invention provides an alternative strategy for baculovirus-mediated foreign gene expression: the promoters from immediate-early or delayed-early baculovirus viral genes were used to obtain the continuous ...
    • Tjalkens, Ronald B.; Safe, Stephen (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-11-12)
      Presented herein are diindolylmethane derivative compounds useful for the prevention and or treatment of neurological conditions, including neurological conditions related to neuroinflammation. One such neurological condition ...
    • Chiou, George C. Y. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1994-09-06)
      A novel compound for the treatment and prevention of ocular and other types of inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the ...
    • Chiou, George C. Y. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1993-03-16)
      A novel compound for the treatment and prevention of ocular inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the treatment of ...
    • Chiou, George C. Y. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1993-03-30)
      A novel compound for the treatment and prevention of ocular inflammation is disclosed. The compound, OB-104, is effective at both the early and late phases of inflammation.
    • Bix, Gregory J.; Wright, Sarah; Griswold-prenner, Irene (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2016-06-07)
      The application reports that perlecan domain V (DV) or the LG3 domain thereof reduces deposition and toxicity of Aβ peptide, the major component of plaques in Alzheimer's disease. Methods of using DV, LG3 and related ...
    • Ficht, Allison R.; Carson, Ken; Sheffield, Cynthia; Waite, John Herbert (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-01-31)
      The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide for mixed and extended ...
    • Ficht, Allison R.; Carson, Kenneth; Sheffield, Cynthia; Waite, John Herbert (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-03-23)
      The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide for mixed and extended ...
    • Cuero, Raul G.; Mckay, David S. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-06-05)
      The present disclosure relates to a composition including an extract from an Acidithiobacillus bacteria or a yeast extracted after exposure of the bacteria to UV radiation. The disclosure further relates to a method of ...
    • Adams, Leslie Garry; Crawford, Richard P.; Davis, Donald S.; Ficht, Thomas A.; Smith, Roger III; Sowa, Blair A.; Templeton, Joe W.; Williams, John D.; Wu, Albert M. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1998-02-17)
      The present invention is an improved vaccine against Brucella abortus which permits differentiation between vaccinated and field strain infected cattle. The vaccine can be administered in two different forms: (1) cell ...
    • Samuel, James E.; Van Schaik, Erin J.; Gregory, Anthony E. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-04-06)
      A vaccine includes at least one bacterial antigen capable of producing an immune response in a host when the vaccine is administered at a dose that is sufficient for preventing or treating Q fever in the host. The vaccine ...